1,400
Participants
Start Date
October 30, 2020
Primary Completion Date
April 30, 2022
Study Completion Date
May 30, 2023
Rotavirus RV3 Vaccine (Bio Farma)
Each 1 mL dose of the final product of oral liquid rotavirus vaccine contains \> 5x10\^6 fcfu/mL rotavirus vaccine strain RV3
Placebo
Each 1 mL dose of placebo contains 30% of sucrose in DMEM
Dr. Moewardi District Hospital, Surakarta
Gajahan Primary Health Center, Surakarta
Gambirsari Primary Health Center, Surakarta
Pajang Primary Health Center, Surakarta
Sangkrah Primary Health Center, Surakarta
Sibela Primary Health Center, Surakarta
Bayat Primary Health Center, Yogyakarta
dr. Soeradji Tirtonegoro General Hospital, Yogyakarta
Gantiwarno Primary Health Center, Yogyakarta
Jogonalan 1 Primary Health Center, Yogyakarta
Jogonalan 2 Primary Health Center, Yogyakarta
Karanganom Primary Health Center, Yogyakarta
Kebonarum Primary Health Center, Yogyakarta
Kebondalem Lor Primary Health Center, Yogyakarta
Klaten Selatan Primary Health Center, Yogyakarta
Ngawen Primary Health Center, Yogyakarta
Pedan Primary Health Center, Yogyakarta
Prambanan Primary Health Center, Yogyakarta
Trucuk 1 Primary Health Center, Yogyakarta
Trucuk 2 Primary Health Center, Yogyakarta
Wedi Primary Health Center, Yogyakarta
Lead Sponsor
PT Bio Farma
INDUSTRY